JNC: Prognostic value of myocardial perfusion imaging in patients with chronic kidney disease: A systematic review and meta-analysis (Jan/Feb 2022)

Course Overview

This Journal CME activity will provide a prognostic value of myocardial perfusion imaging in patients with chronic kidney disease through a systematic review of the literature and meta-analysis.

Target Audience

This activity is targeted at imaging professionals and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

Learner Objectives

After reading and reflecting upon this article in the Journal Nuclear Cardiology, the learner should be able to:

• Evaluate the role of MPS in predicting adverse outcome in patients with CKD
• Underscore the clinical value of MPS findings to obtain a prognostic parameter useful in management of patients with CKD
• Describe the incidence rate ratio for the occurrence of adverse cardiovascular events in CKD patients with abnormal and normal myocardial perfusion
• Provide indication to facilitate better understanding of MPS results for appropriate therapeutic strategies

Overall Goal

The purpose of this CME activity in the Journal of Nuclear Cardiology is to increase the learners’ competence in the application of nuclear cardiology strategies in clinical practice.

Accreditation and Continuing Education Credit

Evaluation Deadlines: AMA PRA Category 1 Credits™, ARRT Category A, and Participation Credits = January 16, 2023

The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credits for Technologists.

Continuing Education Term of Approval

Release Date: January 17, 2022
Expiration Date: January 16, 2023

Summary


Availability:	Retired


Cost:	Physician & Scientist: $0.00 International Emerging Markets: $0.00 International Physician & Scientist: $0.00 Trainee: $0.00 Non-Physician (Member): $0.00 Physician (Non-Member): $50.00 Non-Physician (Non-Member): $50.00


Credit Offered:	No Credit Offered